Enhancing Diversity and Addressing Disparities at the 7th Cancer Cachexia Conference

第七届癌症恶病质会议增强多样性并解决差异

• 批准号: 10827795
• 负责人: Teresa A Zimmers
• 金额: $ 1.5万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10827795
• 关键词: Address; Advocacy; Affect; American Association of Cancer Research; Anorexia; Anticachexia Agent; Asia; Australia; Award; Awareness; Basic Science; Biological Markers; Body Weight decreased; Boston; Brazil; Cachexia; Cancer Detection; Caregivers; Cessation of life; Chronic; Clinical; Clinical Sciences; Clinical Trials; Collaborations; Communication; Communities; Country; Dedications; Diagnosis; Disease; Disparity; Distress; District of Columbia; Education; Educational Materials; Emaciation; Equation; Europe; Event; FDA approved; Faculty; Family; Family member; Fostering; Goals; Growth; Inflammation; International; Intervention; Joints; Justice; Knowledge; Life; Malignant Neoplasms; Malignant neoplasm of liver; Malignant neoplasm of pancreas; Masks; Medical; Mentors; Mentorship; Muscular Atrophy; National Cancer Institute; North America; Obesity; Participant; Patient Care; Patient-Focused Outcomes; Patients; Performance Status; Persons; Philadelphia; Physicians; Postdoctoral Fellow; Provider; Request for Proposals; Research; Research Activity; Research Personnel; Research Support; Resources; Scientist; Scotland; Series; Societies; Structure; Syndrome; Training; Translational Research; Treatment Efficacy; Treatment-related toxicity; United Kingdom; Washington; advanced disease; anticancer research; cancer cachexia; cancer therapy; clinical investigation; clinical translation; coronavirus disease; effective therapy; equity, diversity, and inclusion; experience; forging; graduate student; improved outcome; malignant breast neoplasm; meetings; muscle form; outreach; posters; preclinical study; preservation; programs; symposium; tumor; virtual

ABSTRACT This proposal requests partial support for the 7th Cancer Cachexia Conference organized by the Cancer Cachexia Society (CCS), to be held from September 28-30, 2023, in Edinburgh, Scotland. This iteration of the conference follows prior events in Boston, Montreal, Washington DC, Philadelphia, and two virtual versions during COVID. The long-term goal of the conference series is to foster research, awareness, and understanding of cancer cachexia among scientists, clinicians, patients, and caregivers, for the purpose of advancing identification, treatment, and cure for this major unmet medical need. Indeed, cachexia causes considerable patient and family distress and is estimated to cause some 30% of cancer deaths; yet until recently, cachexia was seldom addressed in any of the major cancer meetings. This conference series has served to help grow awareness and research around cancer cachexia and remains the only one devoted solely to this topic. Research in cancer cachexia is small relative to all cancer research and is global, with roughly equivalent research activity in North America, Europe, and Asia and notable efforts in Brazil and Australia. Hence, we have opted to hold the 7th conference in Scotland to facilitate international access and collaboration. The Aims of the 7th Cancer Cachexia Conference are to: 1 - Deliver a rich scientific program for participants while promoting networking and new collaborations. 2- Promote interaction among patients, caregivers, providers, and investigators and develop enduring patient-facing educational material. 3- Provide for training and mentorship of graduate students, postdoctoral associates, and junior faculty. 4-Expand and grow diversity, equity, and inclusion in the conference and the wider field of cancer cachexia research. The impact of this conference will be to promote progress and growth in the clinical investigation of anti-cachexia therapies and to strengthen knowledge, research, and research capacity in cancer cachexia.

摘要 该提案请求部分支持由癌症协会组织的第七届癌症恶病质会议 恶病质协会(CCS)，将于2023年9月28日至30日在苏格兰爱丁堡举行。这个迭代的 会议之前在波士顿、蒙特利尔、华盛顿特区、费城举行，并有两个虚拟版本 在COVID期间。该系列会议的长期目标是促进研究、意识和理解 在科学家、临床医生、患者和照顾者中传播癌症恶病质，以促进 识别、治疗和治愈这一重大的未得到满足的医疗需求。的确，恶病质会引起相当大的 病人和家人的痛苦，据估计导致了大约30%的癌症死亡；然而直到最近，恶病质 很少在任何主要的癌症会议上发表讲话。这一系列会议帮助推动了 关于癌症恶病质的认识和研究，仍然是唯一专门致力于这一主题的。研究 在癌症中，恶病质相对于所有癌症研究来说都很小，而且是全球性的，研究活动大致相同。 在北美、欧洲和亚洲，以及在巴西和澳大利亚的显著努力。因此，我们选择持有 第七次会议在苏格兰举行，以促进国际准入和合作。第七代巨蟹座的目标 恶病质会议的目的是：1-为与会者提供丰富的科学计划，同时促进网络和 新的合作。2-促进患者、护理人员、提供者和调查人员之间的互动，并发展 经久不衰的面向病人的教育材料。3-为研究生提供培训和指导， 博士后助理和初级教员。4-扩大和提高会议的多样性、公平性和包容性 以及更广泛的癌症恶病质研究领域。这次会议的影响将是促进进展和 在抗恶病质疗法的临床研究中的增长，并加强知识，研究和 癌症恶病质的研究能力。